NCT00527254View on ClinicalTrials.gov

Telemedicine Influence in the Follow up of the Type 2 Diabetes Patient

NACompletedINTERVENTIONAL

Enrollment

328

Participants

Timeline

Start Date

October 31, 2003

Study Completion Date

June 30, 2005

Conditions

Type 2 DiabetesTelemedicineSelf Monitoring Blood GlucosePrimary Care

Interventions

DEVICE

Telemedicine system

Possibility of sending the SMBG values of the patients to a web page via phone mobile sms messages. The HCP had a password access to this web page to check the blood glucose values of the patients and if necessary send to them sms messages with recommendations.

Trial Locations (1)

29001

Province of Malaga Health Department, Málaga

All Listed Sponsors

collaborator

Roche Diabetes Care

INDUSTRY

lead

Province of Malaga Health Department

OTHER_GOV

NCT00527254 - Telemedicine Influence in the Follow up of the Type 2 Diabetes Patient | Biotech Hunter | Biotech Hunter